Consumer violation penalties NIS 1.9m

The legal department of the Ministry of Industry, Trade and Labor dealt with a total of 1,529 consumer complaints in 2006, out of which 169 indictments were submitted.

By SHARON WROBEL
February 7, 2007 07:32

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

The legal department of the Ministry of Industry, Trade and Labor dealt with a total of 1,529 consumer complaints in 2006, out of which 169 indictments were submitted. Eighty-five of those cases reached the country's court houses, resulting in penalty payments of a total of NIS 1.9 million. Supervisors at the ministry conducted 45,830 inspections across the country last year, an increase of 1% over the previous year, out of which 27,142, were price presentation inspections.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS